Researchers found that a specific molecular process controls B cell activation and differentiation, leading to impaired antibody production. The study highlights the importance of genes like IL-21 receptor, STAT3, and CD25 in B cell function, with mutations causing debilitating effects in patients.
Scientists have developed a system that can construct its own network of tracks, transport cargo, and dismantle the tracks using DNA and nano-scale motors. The system is powered by ATP fuel and uses motor proteins to control the movement of cargo across the network.
Researchers analyzed 21,309 Chinese individuals and identified only two independent low-frequency coding variants with moderate effect on disease risk. These findings suggest that the overall genetic risk for psoriasis is largely driven by other factors, contradicting previous assumptions about the role of coding variants.
Studies show that absence of serotonin receptors during early development leads to highly aggressive behavior in mice, while adolescents exhibit increased impulsivity to danger. The findings have potential applications for treating disorders related to impulsivity and aggression.
The new peer-reviewed journal brings together knowledge on pneumonia's pathogenesis, treatment, and prevention, featuring original research articles and expert analysis.
A new EU fishing ban faces criticism from researchers who say it may not be enough to ensure sustainable fisheries. The study, published in the journal Fisheries Research, highlights the need for a more comprehensive approach to reducing fishing mortality and increasing selective fishing practices.
A new '1-stop' radiotherapy technique has shown non-inferiority to traditional treatment in reducing breast cancer recurrence. The TARGIT trial found a single dose of targeted radiation during or soon after surgery reduced local recurrence risk by 80% compared to standard radiotherapy.
This year's AAPS Fellows were recognized for their research and scholarly contributions in various fields of pharmaceutical sciences, including immunology, drug delivery, and clinical pharmacology. Notable recipients include Sathy Balu-Iyer, who developed a mechanistic model to understand immunogenicity of biotherapeutics.
New research reveals that sleep plays a crucial role in consolidating visual task learning through specific brain frequencies. Brainwaves of 15 volunteers were measured during sleep and training to demonstrate increased sigma power in the visual cortical area, leading to improved performance on the task.
Researchers identify 18F-NaF as a promising tool to detect high-risk coronary plaques in patients with stable and unstable heart disease. The study suggests that this non-invasive technique could transform the way doctors identify, manage, and treat patients at risk of heart attacks.
Researchers have identified a molecule that regulates fibrotic disease, offering hope for treating damaged organs. Removing this molecule or using experimental drugs has been shown to reduce scar tissue in mice, with implications for human treatment.
Researchers at the University of Adelaide and The University of Queensland discovered that zinc 'jams shut' a protein transporter in deadly bacteria, preventing manganese uptake. This finding opens the way for designing antibacterial agents to target essential transporters.
Research reveals new roles for sex hormones like estrogen in the cognitive function of females, including memory and interpreting social cues. Estrogen replacement therapy may help prevent stress-related memory loss in post-menopausal women.
Researchers Leaf Huang, Sukyung Woo, Shyh-Dar Li, and Raj Suryanarayanan received awards for their groundbreaking work on non-viral gene therapy, tumor evasion mechanisms, nanomedicine, and physical pharmacy. Their research holds promise for future development of clinically effective gene and anti-cancer therapies.
Scientists have found the cause of a genetic disease, pancreatic agenesis, in previously unexplored regions of DNA. The condition affects babies and leads to diabetes and digestive issues.
Research at the University of Montreal found that even 20 minutes of moderate exercise three times a week during pregnancy enhances brain activity in newborns. The study suggests that this early stimulation can lead to improved cognitive and motor development in children.
Researchers discovered genetic differences between African Americans and European Americans that affect blood clot formation, providing a potential explanation for the racial disparity in heart disease outcomes. The study highlights the need for personalized treatment approaches based on an individual's genetic profile.
New studies reveal exercise and diet play crucial roles in treating depression, aging, and learning in teenagers. Lifestyle changes, such as yoga, meditation, and regular exercise, show promise for preserving movement function, improving memory, and boosting mood.
Researchers at UC San Diego have developed a new single-cell genome sequencing technique that confines genome amplification to fluid-filled wells with a volume of just 12 nanoliters. This approach enables the generation of more complete genome sequences from single cells, including E. coli and individual neurons from the human brain.
A recent study by Gladstone researchers reveals that specific stretches of DNA, called human accelerated regions (HARs), control the development of uniquely human characteristics. HARs were found to be crucial in human ancestors becoming distinct from our closest primate relatives.
Scientists have gained a deeper understanding of multiple sclerosis, revealing warning signs and potential treatments. Researchers found that antibodies can break past the brain's protective barrier to attack the optic nerves and spinal cord, causing MS symptoms.
A study led by UC San Diego scientists reveals a new way in which RNA-binding proteins govern regulated gene expression, expanding potential targets for therapies. The discovery challenges existing models and has implications for the treatment of neurodevelopmental disorders and certain cancers.
Scientists at Saint Louis University have discovered a potential novel therapeutic approach to treat fibrotic diseases by targeting the Transforming Growth Factor (TGF) beta protein. Removing a gene that makes alpha v integrins blocks TGF beta activation, and treatment with a small molecule compound replicates this effect.